beta-aspartylhydroxamic acid

RN given refers to (DL)-isomer

Also Known As:

D-aspartic acid beta-hydroxamate; aspartate-beta-hydroxamate; aspartic acid beta-hydroxamate; beta-aspartylhydroxamate; beta-aspartylhydroxamic acid, (D)-isomer; beta-aspartylhydroxamic acid, (L)-isomer; DL-asparagine, N-hydroxy-

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Amino Acids: 30675

Related Diseases

1.	Leukemia 09/30/1991 - "D and L isomers of aspartic acid beta-hydroxamate (respectively DAH and LAH) were compared for their in vitro and in vivo activity against the murine leukemia L5178Y and their tolerance in vivo in DBA/2 mice. " 09/30/1991 - "Anti-tumoral activity of L and D isomers of aspartic acid beta-hydroxamate on L5178Y leukemia." 08/01/1994 - "D-aspartic acid beta-hydroxamate (DAH), an aspartic acid analogue, exerts anti-tumoral activity against murine leukemia L5178Y both in vitro and in vivo. "
2.	Acute Erythroblastic Leukemia (Erythroleukemia) 08/01/1994 - "Therapeutic effects of D-aspartic acid beta-hydroxamate (DAH) on Friend erythroleukemia."

Related Drugs and Biologics

1.	Therapeutic Uses
2.	Aspartic Acid (Aspartate)